Paxillin Antikörper (AA 327-568)
Kurzübersicht für Paxillin Antikörper (AA 327-568) (ABIN7624223)
Target
Alle Paxillin (PXN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 327-568
-
Verwendungszweck
- Paxillin (PXN) Polyclonal Antibody
-
Sequenz
- Ser327~Phe568
-
Produktmerkmale
- The Paxillin (PXN) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Paxillin (PXN)
-
Andere Bezeichnung
- PXN
-
Gen-ID
- 360820
-
UniProt
- Q66H76
-
Pathways
- MAPK Signalweg, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Target
-